Mission Creek Capital Partners, Inc.
Position in GILD — Gilead Sciences, Inc.
CIK 1801583
SAN FRANCISCO, CA
Position in GILD
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$321,156
+$75,587 QoQ
Shares Held
2,542
+44.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#1,611
of 2,266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Mission Creek Capital Partners, Inc. holds $22,770,041 across 9 Drug Manufacturers - General names. GILD ranks #7 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
37,974 | $9,644,256 | |
| 2 | LLY |
ELI LILLY & Co
|
4,541 | $5,446,612 | |
| 3 | AMGN |
Amgen Inc
|
14,051 | $5,088,148 | |
| 4 | ABBV |
AbbVie Inc.
|
17,933 | $887,331 | |
| 5 | PFE |
Pfizer Inc
|
22,248 | $535,731 | |
| 6 | MRK |
Merck & Co., Inc.
|
3,080 | $395,780 | |
| 7 | GILD |
Gilead Sciences, Inc.
This page
|
2,542 | $321,156 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
4,250 | $244,885 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $321,156 | 2,542 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $245,569 | 1,762 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $224,859 | 1,832 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $209,346 | 1,886 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $209,100 | 1,886 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $211,326 | 1,886 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $281,266 | 3,045 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $255,292 | 3,045 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $227,236 | 3,312 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $485,134 | 6,623 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $994,964 | 12,282 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,027,802 | 13,715 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,075,511 | 13,955 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,257,493 | 15,156 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,305,692 | 15,209 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $955,022 | 15,481 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $967,697 | 15,656 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $933,721 | 15,706 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $1,213,095 | 16,707 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,276,369 | 18,273 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,290,642 | 18,743 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $1,255,502 | 19,426 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $1,147,081 | 19,689 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $1,250,593 | 19,791 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $610,365 | 7,933 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $594,940 | 7,958 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||